Michael T Kovalchik, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 780 Litchfield St, Suite200, Torrington, CT 06790 Phone: 860-489-1984 Fax: 860-496-2195 |
News Archive
In the first study of its kind, researchers from five institutions from the UK and U.S. collaborating to determine the long-term outcomes of children with epilepsy found that outcomes varied despite similar short-term morbidity among the originally surveyed children when they were followed up within 10 years post-occurrence.
Research conducted by Allison Berrier, PhD, Assistant Professor of Oral and Craniofacial Biology at the LSU Health Sciences Center New Orleans School of Dentistry, and colleagues, provides insights that may help scientists design novel approaches to control wound healing and fight diseases such as cancer and fibrosis.
Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the BCL6 protein could potentially be used as a marker to predict clinical outcomes of patients suffering from Glioblastoma Multiforme, the most malignant cancer of the brain.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that it has received $426,000 in grant funding under the Qualifying Therapeutic Discovery Project (QTDP) Program. The program, funded through the US Patient Protection and Affordable Care Act of 2010, supports therapeutic discovery programs.
› Verified 6 days ago